Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ArQule Inc (NASDAQ:ARQL)

1.61
Delayed Data
As of Jul 25
 -0.02 / -1.23%
Today’s Change
1.37
Today|||52-Week Range
2.65
-25.81%
Year-to-Date
No recent news for ArQule Inc.

Today’s Trading

Previous close1.63
Today’s open1.64
Day’s range1.59 - 1.67
Volume31,282
Average volume (3 months)137,684
Market cap$115.8M
Dividend yield--
Data as of 07/25/2016

Growth & Valuation

Earnings growth (last year)+40.54%
Earnings growth (this year)-55.68%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)-0.13%
P/E ratioNM
Price/Sales12.13
Price/Book3.52

Competitors

 Today’s
change
Today’s
% change
ADHDAlcobra Ltd-0.03-0.72%
PRQRProQR Therapeutics N...-0.02-0.41%
TKAITokai Pharmaceutical...-0.09-1.70%
VVUSVIVUS Inc-0.05-4.31%
Data as of 9:09am ET, 07/26/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$11.2M
Annual profit (last year)-$13.8M
Net profit margin-122.56%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Paolo Pucci
President &
Chief Operating Officer
Peter S. Lawrence
Corporate headquarters
Burlington, Massachusetts

Forecasts

Partner Offers

Search for Jobs